This is a pooled fund: many plans invest in it, and it holds the underlying securities.
This filing is a Direct Filing Entity (DFE) — a master trust or collective investment trust that pools assets from multiple participating plans. It does not have plan participants of its own, and the Plan Health Score formula doesn’t apply. Individual participant-facing plans that invest in this trust are the appropriate target for fiduciary analysis.
Cited interest vs pooled assets: cited interest sums what each participating plan reported holding in this trust, measured at that plan’s own year-end — and those filings span different years. Pooled assets is this single filing’s balance at one date. They’re independent measurements, so cited interest can land slightly above or below the pooled balance and won’t reconcile exactly.
Why no Schedule of Assets here? DFE holdings often live on the master trust’s own audited statement, not as a 4i schedule on the participating plans’ filings. We’re extending the parsing pipeline to cover DFE filings — see Methodology.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LP | 36-4395128 | — | NONE | $331K | — |
| KPMG LLP | 13-5565207 | — | NONE | $54K | — |
| T. ROWE PRICE ASSOCIATES, INC. | 52-0556948 | — | NONE | $34K | — |
| JP MORGAN CHASE BANK | 13-4994650 | — | NONE | $8K | — |
| PI | Investment | Type | Shares / units | Cost | Current value | % of plan |
|---|---|---|---|---|---|---|
| Da Vinci Private Equity II | — | — | $6.5M | $7.0M | 7.5% | |
| SBCVC Fund IV | — | — | $4.0M | $6.9M | 7.3% | |
| GC Equity Partners Fund III | — | — | $4.3M | $6.0M | 6.3% | |
| RPEV I-B | — | — | $1.5M | $5.5M | 5.9% |
| Banyan Capital Fund II | — | — | $822K | $5.4M | 5.8% |
| Trustbridge Partners IV | — | — | $3.7M | $5.2M | 5.5% |
| JPMorgan US Government Money Market Fund | — | — | $4.7M | $4.7M | 5.0% |
| Baring Vostok Private Equity Fund V LP | — | — | $3.2M | $4.3M | 4.6% |
| Casrev Fund II 20 | — | — | — | $4.1M | 4.4% |
| Matrix Partners India II | — | — | $1.8M | $3.9M | 4.1% |
| Turkish Private Equity Fund III | — | — | $3.1M | $3.6M | 3.9% |
| CVC Capital Partners Asia Pacific IV | — | — | $2.8M | $3.4M | 3.6% |
| Bain Capital Asia Fund III | — | — | $2.7M | $3.1M | 3.3% |
| Matrix Partners China II | — | — | $1.8M | $3.1M | 3.3% |
| Capitalworks Private Equity Fund II | — | — | $2.8M | $2.9M | 3.1% |
| Advantech Capital | — | — | $1.4M | $2.6M | 2.8% |
| LC Fund VI | — | — | $2.2M | $2.3M | 2.5% |
| Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value Accel India Venture Fund III | — | — | $1.3M | $2.3M | 2.4% |
| CMC Capital Partners | — | — | $2.0M | $2.2M | 2.4% |
| IDG-Accel China Capital II | — | — | $2.2M | $1.9M | 2.0% |
| Kalaari Capital Partners II | — | — | $2.4M | $1.7M | 1.8% |
| IDG-Accel China Growth Fund III | — | — | $2.2M | $1.6M | 1.7% |
| CDH China Fund V | — | — | $2.3M | $1.4M | 1.5% |
| Monashees Capital VI | — | — | $1.1M | $1.3M | 1.3% |
| Bain Capital Asia Fund II | — | — | $901K | $1.2M | 1.3% |
| Boyu Capital Fund II | — | — | $1.4M | $1.2M | 1.3% |
| KV Asia Capital Fund I 0 | — | — | — | $1.1M | 1.2% |
| Matrix Partners India II Extension | — | — | $638K | $1.0M | 1.1% |
| Baring Vostok Fund V Supplemental Fund | — | — | $1.8M | $908K | 1.0% |
| Redview Capital | — | — | $1.3M | $683K | 0.7% |
| Northstar Equity Partners III | — | — | $1.2M | $407K | 0.4% |
| LC Fund V | — | — | $2.2M | $341K | 0.4% |
| KPCB China Fund II | — | — | $1.1M | $328K | 0.3% |
| Victoria South American Partners II | — | — | $1.9M | $236K | 0.3% |
| Ethos U.S. Dollar Fund V-B | — | — | $2.1M | $9K | <0.1% |
| ChrysCapital VI 0 | — | — | — | $4K | <0.1% |
